Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 133 Neoplasms 114 Prostatic Neoplasms 63 Lung Neoplasms 47 Head and Neck Neoplasms 46 Colorectal Neoplasms 35 Ovarian Neoplasms 33 Uterine Cervical Neoplasms 28 Endometrial Neoplasms 23 Motor Activity 22 Neoplasm Metastasis 20 Multiple Myeloma 19 Brain Neoplasms 19 Pancreatic Neoplasms 18 Rectal Neoplasms 17 Lymphoma 16 Fatigue 16 Carcinoma, Non-Small-Cell Lung 16 Pain 15 Gastrointestinal Neoplasms 15 Colonic Neoplasms 15 Leukemia 14 Depression 14 Oropharyngeal Neoplasms 13 Urinary Bladder Neoplasms 12 Melanoma 12 Hematologic Neoplasms 12 Esophageal Neoplasms 12 Anxiety Disorders 12 Stomach Neoplasms 11

Interventions

Ultrasonic Waves 1 Tobacco Use Cessation Devices 1 Therapeutics 1 Surveys and Questionnaires 1 Patient Reported Outcome Measures 1 Nicotine Replacement Therapy 1 Nicotine Chewing Gum 1 Ethanol 1 Educational Status 1 Dosage Forms 1 Acceptance and Commitment Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Substance-Related Disorders × Surveys and Questionnaires × Clear all

NCT05684939 2023-06-13

CAPS

University Hospital, Clermont-Ferrand

Neoplasms, Pain, Substance-Related Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚡